Retrieve available abstracts of 21 articles: HTML format
Single Articles
February 2025
ALI FS, Nguyen MH, Hernaez R, Huang DQ, et al AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B
Virus Reactivation in At-Risk Individuals.
Gastroenterology. 2025;168:267-284. PubMedAbstract available
January 2025
KUMAR N, Chaudhary A Comments on "Recompensation of Chronic Hepatitis C-Related Decompensated
Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study
From a Hepatitis C Virus Elimination Program".
Gastroenterology. 2025 Jan 30:S0016-5085(25)00326. PubMed
November 2024
MEZZACAPPA C Gastro Digest: The Revised REACH-B Model Predicts Hepatocellular Carcinoma in
Patients with Chronic Hepatitis B.
Gastroenterology. 2024 Nov 30:S0016-5085(24)05756. PubMed
ZHANG X, Klohn M, Ouwerkerk-Mahadevan S, Jagst M, et al A pan-genotypic hepatitis E virus replication inhibitor with high potency in a
rat infection model.
Gastroenterology. 2024 Nov 22:S0016-5085(24)05696. PubMedAbstract available
August 2024
PREMKUMAR M, Dhiman RK, Duseja A, Mehtani R, et al Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following
direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination
program.
Gastroenterology. 2024 Aug 22:S0016-5085(24)05359. PubMedAbstract available
TRAN CS, Kersten J, Yan J, Breinig M, et al Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for
Invasiveness of Liver Cancer Cells.
Gastroenterology. 2024;167:522-537. PubMedAbstract available
July 2024
MEZZACAPPA C Gastro Digest: Integrated telemedicine to treat HCV through opioid treatment
programs.
Gastroenterology. 2024 Jul 16:S0016-5085(24)05213. PubMed
June 2024
LIAW YF Prediction of Clinical Relapse and HBsAg Loss After Cessation of Anti-HBV
Therapy.
Gastroenterology. 2024;166:1193. PubMed
May 2024
GOUTTENOIRE J, Neyts J A hepatitis E virus infection model in the Mongolian Gerbil: ready for antiviral
and vaccine studies.
Gastroenterology. 2024 May 23:S0016-5085(24)04938. PubMed
April 2024
GUTIERREZ SANCHEZ LH, Ibrahim SH Severe Acute Hepatitis of Unknown Etiology in Children: New Virus or Immune
Dysregulation.
Gastroenterology. 2024 Apr 23:S0016-5085(24)00481. PubMed
LIU T, He Q, Yang X, Li Y, et al An Immunocompetent Mongolian Gerbil Model for Hepatitis E Virus Genotype 1
Infection.
Gastroenterology. 2024 Apr 5:S0016-5085(24)00364. PubMedAbstract available
February 2024
TRIVEDI PJ, Hirschfield GM, Adams DH, Vierling JM, et al Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis
and Autoimmune Hepatitis: Themes and Concepts.
Gastroenterology. 2024 Feb 9:S0016-5085(24)00165. PubMedAbstract available
HERMS Q, Fuster-Anglada C, Juanola A Pembrolizumab-induced Liver Injury: Beyond Immune-Mediated Hepatitis.
Gastroenterology. 2024 Feb 4:S0016-5085(24)00133. PubMed
January 2024
PISATURO M, Alessio L, de Pascalis S, Messina V, et al A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective,
Multicenter Study in Southern Italy.
Gastroenterology. 2024;166:191-193. PubMed
December 2023
LAI L, Rao C, Liu H An Unusual Cause of Ascites in a Patient with Hepatitis B.
Gastroenterology. 2023 Dec 7:S0016-5085(23)05593. PubMed
November 2023
LENS S Successful HCV viral cure is not the end of the story.
Gastroenterology. 2023 Nov 3:S0016-5085(23)05205. PubMed
October 2023
ZHENG D, Fang Z, Sun J Which is more clinically relevant: end-of-treatment or off-treatment predictors
of hepatitis B relapse and surface antigen loss?
Gastroenterology. 2023 Oct 25:S0016-5085(23)05196. PubMed
LIM SG, Tan YC Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic
Hepatitis B: Better But Not Enough.
Gastroenterology. 2023 Oct 12:S0016-5085(23)05132. PubMed
DARA L, Ghabril M, Phillips E, Kleiner D, et al A 68-year-old woman with unexplained liver enzyme elevation and active chronic
hepatitis: Beware of drug induced autoimmune like hepatitis.
Gastroenterology. 2023 Oct 3:S0016-5085(23)05078. PubMed
September 2023
SONNEVELD MJ, Chiu SM, Park JY, Brakenhoff SM, et al Hepatitis B Virus DNA and Hepatitis B e Antigen Levels at 24 Weeks Off-Treatment
Predict Clinical Relapse and Hepatitis B Antigen Loss in Hepatitis B e
Antigen-Negative Patients Who Discontinued Antiviral Therapy.
Gastroenterology. 2023 Sep 26:S0016-5085(23)05068. PubMedAbstract available
August 2023
CONGLY SE, Brahmania M, Coffin CS Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and
Extending the Dataset.
Gastroenterology. 2023 Aug 17:S0016-5085(23)04891. PubMed